WST West Pharmaceutical Services
West Pharmaceutical Services earnings company data as of 12:59 PM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 29 Oct | EPS | 2.18 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by WST's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $3.9M sold by 2 insiders outside a trading plan
- $2.7M sold by 1 insider under 10b5-1 plans
-
Annette F Favorite Sr. VP & Chief HR OfficerPlanned sale$2.7M 7,524 shares at $355.03 26% of stakeTraded Sep 11–15 Filed Sep 15
-
Annette F Favorite Sr. VP & Chief HR OfficerSale$2.8M 8,135 shares at $340.81 33% of stakeTraded Sep 8 Filed Sep 10
-
Annette F Favorite Sr. VP & Chief HR OfficerSale$860K 2,817 shares at $305.20 14% of stakeTraded Apr 27 Filed Apr 29
-
Chad Winters VP, Chief Accounting OfficerSale$269K 896 shares at $300.67 37% of stakeTraded Apr 27 Filed Apr 29
Also filed in the last 12 months, not counted as buying or selling: 19 option exercises, 15 share withholdings for taxes, and 14 stock grants.
SEC filings
Recent issuer filings from EDGAR, 16 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 5.02,7.01,9.01 | Filing Doc | |
| 8-K/A | 1.05,9.01 | Filing Doc | |
| 8-K | 1.05,7.01,9.01 | Filing Doc | |
| 8-K | 5.07,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 5.02,7.01,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.